Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × anlotinib × 1 year × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 6 Carcinoma, Non-Small-Cell Lung 5 Thyroid Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 2 Gallbladder Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Whole-Brain Radiotherapy 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Proteinuria 1 Progression Free Survival(PFS) 1 Platinum-resistant Ovarian Cancer (PROC) 1 Lung Neoplasms 1 Limited Stage Small Cell Lung Cancer 1 Leiomyosarcoma 1 HER2-Negative Breast Cancer 1 Extensive Stage Lung Small Cell Cancer 1 Craniopharyngioma 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1 Advanced Thyroid Cancer Patients Who Received Target Therapy 1

Interventions

pembrolizumab 31 Cisplatin 28 Carboplatin 15 Radiotherapy 14 Paclitaxel 14 Bevacizumab 14 Brachytherapy 13 Colposcopy 11 Specimen Handling 10 Nivolumab 10 Blood Specimen Collection 10 Gemcitabine 9 Radiation 8 Magnetic Resonance Spectroscopy 8 Human Papillomavirus DNA Tests 8 Drug Therapy 8 lenvatinib 6 atezolizumab 6 Platinum 6 dostarlimab 5 Radiotherapy, Intensity-Modulated 5 Methods 5 Biopsy 5 1,2-diaminocyclohexaneplatinum II citrate 5 zimberelimab 4 toripalimab 4 spartalizumab 4 Topotecan 4 Restraint, Physical 4 Pemetrexed 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡